BeOne Medicines (ONC) Free Cash Flow (2015 - 2026)
BeOne Medicines (ONC) reported Free Cash Flow of $158.1 million for Q1 2026, up 1092.51% year-over-year from $13.3 million in Q1 2025, and down 44.25% on a QoQ basis from $283.6 million in Q4 2025.
BeOne Medicines (ONC) has 12 years of Free Cash Flow data on file, last reported at $158.1 million in Q1 2026.
- Quarterly Free Cash Flow rose 1092.51% year-over-year to $158.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 368.26% YoY) and the FY2025 annual result came in at $941.7 million, up 546.44% from the prior year.
- Free Cash Flow eased to $158.1 million in Q1 2026 per ONC's latest filing, from $283.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $408.4 million in Q3 2025 and bottomed at -$675.9 million in Q4 2023.
- The 5-year median for Free Cash Flow is -$205.5 million (2024), against an average of -$148.6 million.
- The widest annual swing landed in 2022, when Free Cash Flow plunged 399.07%; it then surged 1092.51% in 2026.
- Tracing ONC's Free Cash Flow over 5 years: stood at -$439.5 million in 2022, then slumped by 53.78% to -$675.9 million in 2023, then jumped by 159.92% to $405.0 million in 2024, then slipped by 29.99% to $283.6 million in 2025, then plunged by 44.25% to $158.1 million in 2026.
- Per Business Quant, the three latest ONC Free Cash Flow figures stand at $158.1 million (Q1 2026), $283.6 million (Q4 2025), and $408.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 848.30 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 48.67 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 158.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 158.09 Mn |
| Mar 31, 2026 | 158.09 Mn |
| Dec 31, 2025 | 283.57 Mn |
| Dec 31, 2025 | 283.57 Mn |
| Sep 30, 2025 | 408.42 Mn |
| Sep 30, 2025 | 408.42 Mn |
| Jun 30, 2025 | 265.69 Mn |
| Jun 30, 2025 | 265.69 Mn |
| Mar 31, 2025 | -15.93 Mn |
| Mar 31, 2025 | -15.93 Mn |
| Dec 31, 2024 | 405.03 Mn |
| Dec 31, 2024 | 405.03 Mn |
| Sep 30, 2024 | 54.71 Mn |
| Sep 30, 2024 | 54.71 Mn |
| Jun 30, 2024 | -205.54 Mn |
| Jun 30, 2024 | -205.54 Mn |
| Mar 31, 2024 | -338.00 Mn |
| Mar 31, 2024 | -338.00 Mn |
| Dec 31, 2023 | -675.92 Mn |
| Dec 31, 2023 | -675.92 Mn |
| Sep 30, 2023 | 61.29 Mn |
| Sep 30, 2023 | 61.29 Mn |
| Jun 30, 2023 | -476.93 Mn |
| Jun 30, 2023 | -476.93 Mn |
| Mar 31, 2023 | -627.79 Mn |
| Mar 31, 2023 | -627.79 Mn |
| Dec 31, 2022 | -439.55 Mn |
| Dec 31, 2022 | -439.55 Mn |
| Sep 30, 2022 | -670.56 Mn |
| Sep 30, 2022 | -670.56 Mn |
| Jun 30, 2022 | -430.25 Mn |
| Jun 30, 2022 | -430.25 Mn |
| Mar 31, 2022 | -281.69 Mn |
| Mar 31, 2022 | -281.69 Mn |
| Dec 31, 2021 | 221.86 Mn |
| Dec 31, 2021 | 221.86 Mn |
| Sep 30, 2021 | -562.76 Mn |
| Sep 30, 2021 | -562.76 Mn |
| Jun 30, 2021 | -470.28 Mn |
| Jun 30, 2021 | -470.28 Mn |
| Mar 31, 2021 | 94.19 Mn |
| Mar 31, 2021 | 94.19 Mn |
| Dec 31, 2020 | -418.92 Mn |
| Dec 31, 2020 | -418.92 Mn |
| Sep 30, 2020 | -348.21 Mn |
| Sep 30, 2020 | -348.21 Mn |
| Jun 30, 2020 | -270.37 Mn |
| Jun 30, 2020 | -270.37 Mn |
| Mar 31, 2020 | -363.48 Mn |
| Mar 31, 2020 | -363.48 Mn |
| Dec 31, 2019 | -327.54 Mn |
| Dec 31, 2019 | -327.54 Mn |
| Sep 30, 2019 | -258.34 Mn |
| Sep 30, 2019 | -258.34 Mn |
| Jun 30, 2019 | -60.20 Mn |
| Jun 30, 2019 | -60.20 Mn |
| Mar 31, 2019 | -193.80 Mn |
| Mar 31, 2019 | -193.80 Mn |
| Dec 31, 2018 | -168.97 Mn |
| Dec 31, 2018 | -168.97 Mn |
| Sep 30, 2018 | -171.21 Mn |
| Sep 30, 2018 | -171.21 Mn |
| Jun 30, 2018 | -115.45 Mn |
| Jun 30, 2018 | -115.45 Mn |
| Mar 31, 2018 | -114.20 Mn |
| Mar 31, 2018 | -114.20 Mn |
| Dec 31, 2017 | 118.98 Mn |
| Dec 31, 2017 | 118.98 Mn |
| Sep 30, 2017 | -11.96 Mn |
| Sep 30, 2017 | -11.96 Mn |
| Jun 30, 2017 | -58.56 Mn |
| Jun 30, 2017 | -58.56 Mn |
| Mar 31, 2017 | -37.92 Mn |
| Mar 31, 2017 | -37.92 Mn |
| Dec 31, 2016 | -49.32 Mn |
| Dec 31, 2016 | -49.32 Mn |
| Sep 30, 2016 | -15.84 Mn |
| Sep 30, 2016 | -15.84 Mn |
| Jun 30, 2016 | -24.71 Mn |
| Jun 30, 2016 | -24.71 Mn |
| Mar 31, 2016 | -23.14 Mn |
| Mar 31, 2016 | -23.14 Mn |
| Dec 31, 2015 | -14.89 Mn |
| Dec 31, 2015 | -14.89 Mn |
| Sep 30, 2015 | -11.74 Mn |
| Sep 30, 2015 | -11.74 Mn |
| Jun 30, 2015 | -6.30 Mn |
| Jun 30, 2015 | -6.30 Mn |
| Mar 31, 2015 | -6.94 Mn |
| Mar 31, 2015 | -6.94 Mn |